Medicare Enrolled
Dr. Semaan El-Khoury, MD
Legal Medicine · Aulander, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. El-Khoury from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Khoury?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El-Khoury
Dr. Semaan El-Khoury is a legal medicine specialist in Aulander, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. El-Khoury performed 6,324 Medicare services across 3,728 unique beneficiaries.
Between the years covered by Open Payments, Dr. El-Khoury received a total of $11,475 from 53 pharmaceutical and/or device companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in legal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Khoury is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in NC
$11,475 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,324
Medicare services
Top 7% in NC for legal medicine
3,728
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~316 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,021 | $70 | $290 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
646 | $56 | $200 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
559 | $3 | $52 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
501 | $13 | $136 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
447 | $123 | $220 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
421 | $9 | $172 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
287 | $51 | $204 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
244 | $6 | $68 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
206 | $1 | $16 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
204 | $4 | $80 |
| Annual depression screening | 200 | $18 | $72 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
197 | $8 | $70 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
173 | $14 | $110 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
117 | $72 | $274 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
116 | $1 | $20 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
114 | $3 | $64 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
114 | $2 | $60 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
111 | $12 | $50 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
104 | $0 | $20 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
62 | $38 | $100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $40 | $160 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
39 | $35 | $150 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
39 | $30 | $194 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
36 | $98 | $278 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
35 | $6 | $52 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
33 | $4 | $90 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
33 | $37 | $234 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
31 | $143 | $342 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
31 | $213 | $462 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
26 | $149 | $300 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect multiple types of influenza virus. |
25 | $94 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
19 | $8 | $44 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
19 | $4 | $68 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
19 | $26 | $132 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
19 | $60 | $226 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
19 | $143 | $340 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $47 | $382 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,475
Total received (2018-2024)
Avg $1,639/year across 7 years
Top 8% in NC for legal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
816
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,475 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,389
2023
$1,482
2022
$1,031
2021
$1,912
2020
$1,451
2019
$1,780
2018
$2,430
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$310
Lilly USA, LLC
$150
PFIZER INC.
$136
Novo Nordisk Inc
$132
Exact Sciences Corporation
$120
GlaxoSmithKline, LLC.
$113
Merck Sharp & Dohme LLC
$63
Phathom Pharmaceuticals, Inc.
$53
Mylan Specialty L.P.
$50
Bayer Healthcare Pharmaceuticals Inc.
$38
ABBVIE INC.
$36
Novartis Pharmaceuticals Corporation
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Otsuka Pharmaceutical Development & Commercialization, Inc.
$26
Lundbeck LLC
$26
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
Eisai Inc.
$20
Otsuka America Pharmaceutical, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$15
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,594
Novo Nordisk Inc
$1,486
GlaxoSmithKline, LLC.
$1,049
Janssen Pharmaceuticals, Inc
$862
Boehringer Ingelheim Pharmaceuticals, Inc.
$774
PFIZER INC.
$691
Lilly USA, LLC
$660
Novartis Pharmaceuticals Corporation
$606
Amgen Inc.
$532
SANOFI-AVENTIS U.S. LLC
$363
Astellas Pharma US Inc
$347
Takeda Pharmaceuticals U.S.A., Inc.
$201
Exact Sciences Corporation
$196
Bayer Healthcare Pharmaceuticals Inc.
$170
Eisai Inc.
$160
ABBVIE INC.
$147
Amarin Pharma Inc.
$144
AbbVie Inc.
$144
Sunovion Pharmaceuticals Inc.
$133
Merck Sharp & Dohme LLC
$119
UCB, Inc.
$83
Kowa Pharmaceuticals America, Inc.
$83
Mylan Specialty L.P.
$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
Phathom Pharmaceuticals, Inc.
$53
Otsuka America Pharmaceutical, Inc.
$51
E.R. Squibb & Sons, L.L.C.
$46
Horizon Pharma plc
$46
Merck Sharp & Dohme Corporation
$45
Xeris Pharmaceuticals, Inc.
$43
Allergan, Inc.
$40
Biohaven Pharmaceutical Holding Company Ltd.
$39
VYERA PHARMACEUTICALS, LLC
$33
Dexcom, Inc.
$33
Avanir Pharmaceuticals, Inc.
$32
Otsuka Pharmaceutical Development & Commercialization, Inc.
$26
Lundbeck LLC
$26
Bayer HealthCare Pharmaceuticals Inc.
$24
EISAI INC.
$23
Biogen, Inc.
$23
Corcept Therapeutics
$22
Nestle HealthCare Nutrition Inc.
$22
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
Abbott Laboratories
$20
DEXCOM, INC.
$18
Genentech USA, Inc.
$17
Horizon Therapeutics plc
$16
Ironwood Pharmaceuticals, Inc
$14
Daiichi Sankyo Inc.
$14
Ultragenyx Pharmaceutical Inc.
$13
Hikma Pharmaceuticals USA
$13
AbbVie, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$11
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · Briviact · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Daraprim · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · GARDASIL · GARDASIL 9 · GVOKE PFS · HUMALOG · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Leqembi · LifeVest · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · Motegrity · Movantik · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TAGRISSO · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · UTIBRON · UTIBRON NEOHALER · VESICARE · VIMOVO · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6 · YUPELRI · ZENPEP · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for legal medicine in NC.
Geographic Context
Legal medicines within 10 mi
1
Per 100K population
5.7
County median income
$45,931
Nearest hospital
VIDANT ROANOKE CHOWAN HOSPITAL
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. El-Khoury is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NC), with low-engagement industry engagement in the top 8% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. El-Khoury experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. El-Khoury performed 1,021 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Khoury receive payments from pharmaceutical companies?
Yes. Dr. El-Khoury received a total of $11,475 from 53 companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Khoury's costs compare to other legal medicines in Aulander?
Dr. El-Khoury's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Khoury) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Legal Medicines in Aulander
Browse legal medicines in Aulander ranked by procedure volume and transparency data.
Highest volume
Top Legal Medicines in NC
Legal medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Legal Medicines in NC
Which NC legal medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology